sch 23982 has been researched along with antalarmin in 1 studies
| Studies (sch 23982) | Trials (sch 23982) | Recent Studies (post-2010) (sch 23982) | Studies (antalarmin) | Trials (antalarmin) | Recent Studies (post-2010) (antalarmin) |
|---|---|---|---|---|---|
| 87 | 0 | 0 | 181 | 0 | 76 |
| Protein | Taxonomy | sch 23982 (IC50) | antalarmin (IC50) |
|---|---|---|---|
| Corticotropin-releasing factor receptor 1 | Homo sapiens (human) | 0.0186 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Card, K; Djouma, E; Lawrence, AJ; Lodge, DJ | 1 |
1 other study(ies) available for sch 23982 and antalarmin
| Article | Year |
|---|---|
The CRF1 receptor antagonist, antalarmin, reverses isolation-induced up-regulation of dopamine D2 receptors in the amygdala and nucleus accumbens of fawn-hooded rats.
Topics: Amygdala; Animals; Behavior, Animal; Benzazepines; Brain-Derived Neurotrophic Factor; Dopamine Agonists; Dopamine Antagonists; Male; Nucleus Accumbens; Pyrimidines; Pyrroles; Rats; Rats, Inbred Strains; Receptor, trkB; Receptors, Corticotropin-Releasing Hormone; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Social Isolation; Up-Regulation | 2006 |